Volnay Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 4

Volnay General Information

Description

Provider of transformative and commercially viable cell and gene ventures intended for product development and technology innovation. The company is currently operating in stealth mode.

Contact Information

Website
www.volnaytx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Cambridge, MA
  • United States
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Cambridge, MA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Volnay Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 01-Aug-2024 Completed Startup
1. Early Stage VC 01-Jan-2022 Completed Startup
To view Volnay’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Volnay Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Volnay Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
CU Healthcare Innovation Fund Corporate Venture Capital Minority
Eurofarma Laboratorios Corporation Minority
Mayo Clinic Corporation Minority
Mission BioCapital Venture Capital Minority
To view Volnay’s complete investors history, request access »

Volnay Investments (1)

Volnay’s most recent deal was a Early Stage VC with March Biosciences for . The deal was made on 03-Jan-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
March Biosciences 03-Jan-2025 Early Stage VC Drug Discovery
To view Volnay’s complete investments history, request access »

Ready to get started?

Request a free trial

Volnay FAQs

  • When was Volnay founded?

    Volnay was founded in 2022.

  • Where is Volnay headquartered?

    Volnay is headquartered in Cambridge, MA.

  • What is the size of Volnay?

    Volnay has 7 total employees.

  • What industry is Volnay in?

    Volnay’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Volnay a private or public company?

    Volnay is a Private company.

  • What is Volnay’s current revenue?

    The current revenue for Volnay is .

  • Who are Volnay’s investors?

    CU Healthcare Innovation Fund, Eurofarma Laboratorios, Mayo Clinic, and Mission BioCapital have invested in Volnay.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process